Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Research

• Publication date

  2003-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 14695183
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic significance of morphologic parameters in renal cell carcinoma

  2004influential reference
• Cancer Statistics, 2003

  2003cited by this paper
• The RB and p53 pathways in cancer.

  2002cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR.

  2001cited by this paper
• Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas

  2001cited by this paper
• A gene hypermethylation profile of human cancer.

  2001cited by this paper
• Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.

  2001cited by this paper
• Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.

  2001cited by this paper
• A radical solution to death

  2000cited by this paper
• Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.

  2000cited by this paper
• Aberrant CpG-island methylation has non-random and tumour-type–specific patterns

  2000cited by this paper
• Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3

  2000cited by this paper
• Predicting lung cancer by detecting aberrant promoter methylation in sputum.

  2000cited by this paper
• Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status.

  2000cited by this paper
• Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer.

  2000cited by this paper
• Aberrant methylation of gene promoters in cancer---concepts, misconcepts, and promise.

  2000cited by this paper
• Facile detection of mitochondrial DNA mutations in tumors and bodily fluids.

  2000cited by this paper
• E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia.

  2000cited by this paper
• Diagnosis of renal cancer by molecular urinalysis.

  1999cited by this paper
• Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers.

  1999cited by this paper
• Cancer-epigenetics comes of age

  1999cited by this paper
• The Genetic Basis of Human Cancer

  1999cited by this paper
• Histopathology and molecular genetics of renal tumors toward unification of a classification system.

  1999cited by this paper
• Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.

  1999cited by this paper
• Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer.

  1999cited by this paper
• Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma.

  1998cited by this paper
• Alterations in DNA methylation: a fundamental aspect of neoplasia.

  1998cited by this paper
• Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia.

  1998cited by this paper
• TNM Classification of Malignant Tumors

  1998cited by this paper
• Bladder cancer.

  1998cited by this paper
• Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis.

  1998cited by this paper
• The Genetic Basis of Human Cancer

  1997cited by this paper
• Classification of renal cell carcinoma

  1997cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996influential reference
• Renal-cell carcinoma.

  1996cited by this paper
• Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas.

  1995cited by this paper
• Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.

  1994cited by this paper
• A Laboratory manual

  1989cited by this paper
• Prognostic significance of morphologic parameters in renal cell carcinoma

  1982cited by this paper
• Renal cell carcinoma.

  1956cited by this paper

• Epigenetic silencing and CRISPR-mediated reactivation of tight junction protein claudin10b (CLDN10B) in renal cancer

  2025cites this paper
• Renal cell carcinoma detection: a systematic review in diagnostic urinary biomarkers

  2025cites this paper
• DNA Methylation in Urine and Feces Indicative of Eight Major Human Cancer Types Globally

  2025cites this paper
• Correlation-Adjusted Simultaneous Testing for Ultra High-dimensional Grouped Data

  2024cites this paper
• Evaluation of Sensitive Urine DNA-based PENK Methylation Test for Detecting Bladder Cancer in Patients with Hematuria.

  2023cites this paper
• Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting

  2023cites this paper
• Promoter methylation levels of RASSF1 and ATIC genes are associated with lung cancer in Iranian patients

  2023cites this paper
• Epigenetics in advanced renal cell carcinoma: potential new targets.

  2022cites this paper
• LiKidMiRs: A ddPCR-Based Panel of 4 Circulating miRNAs for Detection of Renal Cell Carcinoma

  2022cites this paper
• Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma

  2022cites this paper
• Epigenetic Biomarkers of Renal Cell Carcinoma for Liquid Biopsy Tests

  2021cites this paper
• The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments

  2021cites this paper
• Clinical significance of novel DNA methylation biomarkers for renal clear cell carcinoma

  2021cites this paper
• SOX17 Antagonizes the WNT Signaling Pathway and is Epigenetically Inactivated in Clear-Cell Renal Cell Carcinoma

  2021cites this paper
• Tissue-Specific Cell Signaling

  2020influential citation
• Signaling Pathways Involved in Kidney and Urinary Tract Physiology and Pathology

  2020cites this paper
• Epigenetic Dysregulation in Advanced Kidney Cancer

  2020cites this paper
• Systematic Review and STARD Scoring of Renal Cell Carcinoma Circulating Diagnostic Biomarker Manuscripts

  2020cites this paper
• DNA methylation of sarcosine dehydrogenase (SARDH) loci as a prognosticator for renal cell carcinoma.

  2019cites this paper
• Diagnostic DNA Methylation Biomarkers for Renal Cell Carcinoma: A Systematic Review.

  2019cites this paper
• DNA-Methylation-Based Detection of Urological Cancer in Urine: Overview of Biomarkers and Considerations on Biomarker Design, Source of DNA, and Detection Technologies

  2019cites this paper
• RASSF1A promoter methylation correlates development, progression, and poor cancer-specific survival of renal cell carcinoma: trial sequential analysis

  2018cites this paper
• The Role of DNA Methylation in Renal Cell Carcinoma

  2018cites this paper
• RASSF 1 A promoter methylation correlates development , progression , and poor cancer-specific survival of renal cell carcinoma : trial sequential analysis

  2018cites this paper
• Epigenetics in renal cell cancer: mechanisms and clinical applications

  2018cites this paper
• Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel

  2017cites this paper
• The epigenetic landscape of renal cancer

  2017cites this paper
• Clinical significance of p16INK4A and p14ARF promoter methylation in renal cell carcinoma: a meta-analysis

  2017influential citation
• Antcin-H Isolated from Antrodia cinnamomea Inhibits Renal Cancer Cell Invasion Partly through Inactivation of FAK-ERK-C/EBP-β/c-Fos-MMP-7 Pathways

  2017cites this paper
• TIMP3 promoter hypermethylation contributes to the risk of renal cell carcinoma: A meta-analysis

  2017influential citation
• The Clinicopathological Significance of Epigenetic Silencing of VHL Promoter and Renal Cell Carcinoma: A Meta-Analysis

  2016cites this paper
• The expression and function of Frizzled-7 in human renal cell carcinoma

  2016cites this paper
• DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects

  2016cites this paper
• Caveolin-1 is a modulator of clonogenicity in renal cell carcinoma

  2015cites this paper
• The role of epigenetics in kidney malignancies

  2015cites this paper
• Aberrant Methylation of RASSF1A gene Contribute to the Risk of Renal Cell Carcinoma: a Meta-Analysis.

  2015cites this paper
• Molecular prognostic markers in renal cell carcinoma

  2015cites this paper
• Development and Testing of Complex Molecular Genetic Diagnosis of Genitourinary System Neoplasms

  2015cites this paper
• RETRACTED CHAPTER: Molecular Testing in Adult Kidney Tumors

  2014cites this paper
• Delineating an epigenetic continuum in head and neck cancer.

  2014cites this paper
• Identifying DNA Methylation Patterns as Novel Urinary Biomarkers for Kidney Function

  2014cites this paper
• Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies

  2014cites this paper
• von Hippel-Lindau exonic methylation analysis using MALDI-TOF mass spectrometry.

  2014cites this paper
• DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma

  2014cites this paper
• Expression profiling and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in sporadic human renal cell carcinoma.

  2014cites this paper
• Genome-Wide Promoter Methylome of Small Renal Masses

  2013cites this paper
• The study of DNA methylation in urological cancer: present and future.

  2013cites this paper
• Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma

  2013cites this paper
• The way Wnt works: Components and mechanism

  2013cites this paper
• Serum DNA hypermethylation in patients with kidney cancer: results of a prospective study.

  2013cites this paper
• Genomics and epigenomics of renal cell carcinoma.

  2013cites this paper
• The study of DNA methylation in urological cancer: present and future

  2013cites this paper
• El estudio de la metilación del ADN en el cáncer urológico: presente y futuro

  2013cites this paper
• The Epigenetics of Renal Cell Tumors: from Biology to Biomarkers

  2012influential citation
• Current Status of Biomarker Discovery in Human clear Cell Renal Cell Carcinoma

  2012cites this paper
• MG 98 , a Second-Generation DNMT 1 Inhibitor , in the Treatment of Advanced Renal Cell Carcinoma

  2012cites this paper
• Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis.

  2012cites this paper
• MG98, a Second-Generation DNMT1 Inhibitor, in the Treatment of Advanced Renal Cell Carcinoma

  2012cites this paper
• Wnt signaling pathways in urological cancers: past decades and still growing

  2012cites this paper
• Methylcap-Seq Reveals Novel DNA Methylation Markers for the Diagnosis and Recurrence Prediction of Bladder Cancer in a Chinese Population

  2012cites this paper
• ЛОКАЛИЗАЦИЯ ТОЧКОВЫХ МУТАЦИЙ В КОДИРУЮЩЕЙ ЧАСТИ ГЕНА VHL ПРИ СВЕТЛОКЛЕТОЧНОМ РАКЕ ПОЧКИ

  2012influential citation
• Methylation of the APAF-1 and DAPK-1 promoter region correlates with progression of renal cell carcinoma in North Indian population

  2012cites this paper
• Epigenetic Alterations in Bladder Cancer and Their Potential Clinical Implications

  2012cites this paper
• The molecular basis for central nervous system primitive neuroectodermal tumour development

  2012cites this paper
• Malignant Renal Tumors

  2012cites this paper
• Genome-Wide DNA Methylation Profiles in Renal Tumors of Various Histological Subtypes and Non-Tumorous Renal Tissues

  2011cites this paper
• Exploitation of Aberrant Signalling Pathways as Useful Targets for Renal Clear Cell Carcinoma Therapy

  2011cites this paper
• Renal Cell Carcinoma

  2011cites this paper
• Epigenetic Alterations as Contributors to the Pathogenesis, Detection, Prognosis and Treatment of Human Pre-invasive Neoplasia

  2011cites this paper
• Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma

  2011cites this paper
• Epigenetics of kidney cancer and bladder cancer.

  2011cites this paper
• Methylation of DNA in cancer.

  2010cites this paper
• Signaling pathways in renal cell carcinoma

  2010cites this paper
• Renal cell carcinoma.

  2010cites this paper
• Long Interspersed Nuclear Element 1 Hypomethylation Is a Marker of Poor Prognosis in Stage IA Non–Small Cell Lung Cancer

  2010cites this paper
• LINE-1 Hypomethylation is a Marker of Poor Prognosis in Stage IA Non-small Cell Lung Cancer

  2010cites this paper
• Cancer biomarkers - current perspectives.

  2010cites this paper
• Epigenetic diagnostics of cancer — the application of DNA methylation markers

  2010cites this paper
• Increase sensitivity in detecting superficial, low grade bladder cancer by combination analysis of hypermethylation of E-cadherin, p16, p14, RASSF1A genes in urine.

  2010cites this paper
• Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics

  2010cites this paper
• Different Angiogenic Potential in Low and High Grade Sporadic Clear Cell Renal Cell Carcinoma Is Not Related to Alterations in the von Hippel–Lindau Gene

  2009cites this paper
• Multigene Methylation Analysis of Conventional Renal Cell Carcinoma

  2009cites this paper
• Identification of Candidate Tumour Suppressor Genes Frequently Methylated in Renal Cell Carcinoma

  2009cites this paper
• Jade-1 inhibits Wnt signaling by ubiquitinating β-catenin and mediates Wnt pathway inhibition by pVHL

  2008cites this paper
• Epigenetics in bladder cancer

  2008cites this paper
• VHL inactivation in sporadic clear cell renal carcinoma

  2008influential citation
• Wnt signaling in renal cancer.

  2008cites this paper
• Genetics and epigenetics of renal cell cancer.

  2008cites this paper
• DNA Methylation in Tumor Diagnosis

  2008cites this paper
• Identification of novel epigenetic markers for clear cell renal cell carcinoma.

  2008cites this paper
• Epigenetic markers in human gliomas: prospects for therapeutic intervention

  2008cites this paper
• Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma

  2008cites this paper
• The Ras-association domain family (RASSF) members and their role in human tumourigenesis

  2007cites this paper
• Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.

  2007cites this paper
• Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools.

  2007cites this paper
• Epigenetics: relations to disease and laboratory findings.

  2007cites this paper
• Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors

  2007cites this paper
• Epigenetics of prostate cancer.

  2007cites this paper
• The Role of RASSF1A Methylation in Cancer

  2007cites this paper
• Promoter Hypermethylation of Tumor Suppressor Genes in Urine from Patients with Cervical Neoplasia

  2007cites this paper